AIMS: To determine, in the context of a trial in which counseling did not improve smoking cessation outcomes, whether this was due to a failure of the conceptual theory identifying treatment targets or the action theory specifying interventions. DESIGN: Data from a randomized clinical trial of smoking cessation counseling and bupropion SR were submitted to multi-level modeling to test whether counseling influenced real-time reports of cognitions, emotions and behaviors, and whether these targets predicted abstinence. SETTING: Center for Tobacco Research and Intervention, Madison, WI. PARTICIPANTS: A total of 403 adult, daily smokers without contraindications to bupropion SR use. Participants were assigned randomly to receive individual counseling or no counseling and a 9-week course of bupropion SR or placebo pill. Cessation counseling was delivered in eight 10-minute sessions focused on bolstering social support, motivation, problem-solving and coping skills. MEASUREMENTS: Pre- and post-quit ecological momentary assessments of smoking behavior, smoking triggers, active prevention and coping strategies, motivation to quit, difficulty quitting and reactions to initial lapses. FINDINGS: Counseling prompted avoidance of access to cigarettes, improved quitting self-efficacy, reduced perceived difficulty of quitting over time and protected against guilt and demoralization following lapses. Results also supported the importance of limiting cigarette access, receiving social support, strong motivation and confidence and easing withdrawal distress during cessation efforts. Quitting self-efficacy and perceived difficulty quitting may partially mediate counseling effects on abstinence. CONCLUSIONS:Smoking cessation counseling may work by supporting confidence about quitting and reducing perceived difficulty quitting. Counseling did not affect other targets that protect against relapse.
RCT Entities:
AIMS: To determine, in the context of a trial in which counseling did not improve smoking cessation outcomes, whether this was due to a failure of the conceptual theory identifying treatment targets or the action theory specifying interventions. DESIGN: Data from a randomized clinical trial of smoking cessation counseling and bupropion SR were submitted to multi-level modeling to test whether counseling influenced real-time reports of cognitions, emotions and behaviors, and whether these targets predicted abstinence. SETTING: Center for Tobacco Research and Intervention, Madison, WI. PARTICIPANTS: A total of 403 adult, daily smokers without contraindications to bupropion SR use. Participants were assigned randomly to receive individual counseling or no counseling and a 9-week course of bupropion SR or placebo pill. Cessation counseling was delivered in eight 10-minute sessions focused on bolstering social support, motivation, problem-solving and coping skills. MEASUREMENTS: Pre- and post-quit ecological momentary assessments of smoking behavior, smoking triggers, active prevention and coping strategies, motivation to quit, difficulty quitting and reactions to initial lapses. FINDINGS: Counseling prompted avoidance of access to cigarettes, improved quitting self-efficacy, reduced perceived difficulty of quitting over time and protected against guilt and demoralization following lapses. Results also supported the importance of limiting cigarette access, receiving social support, strong motivation and confidence and easing withdrawal distress during cessation efforts. Quitting self-efficacy and perceived difficulty quitting may partially mediate counseling effects on abstinence. CONCLUSIONS: Smoking cessation counseling may work by supporting confidence about quitting and reducing perceived difficulty quitting. Counseling did not affect other targets that protect against relapse.
Authors: S Shiffman; M H Balabanis; J A Paty; J Engberg; C J Gwaltney; K S Liu; M Gnys; M Hickcox; S M Paton Journal: Health Psychol Date: 2000-07 Impact factor: 4.267
Authors: Thomas H Brandon; Thaddeus A Herzog; Laura M Juliano; Jennifer E Irvin; Amy B Lazev; Vani Nath Simmons Journal: J Abnorm Psychol Date: 2003-08
Authors: Danielle E McCarthy; Thomas M Piasecki; Daniel L Lawrence; Douglas E Jorenby; Saul Shiffman; Timothy B Baker Journal: Addiction Date: 2008-09 Impact factor: 6.526
Authors: Christine E Sheffer; Warren K Bickel; Thomas H Brandon; Christopher T Franck; Darwin Deen; Luana Panissidi; Syed Amir Abdali; Jami C Pittman; Sara E Lunden; Neelam Prashad; Ria Malhotra; Antonio Mantovani Journal: Drug Alcohol Depend Date: 2017-11-04 Impact factor: 4.492
Authors: Rebecca J Evans-Polce; Joao M Castaldelli-Maia; Georg Schomerus; Sara E Evans-Lacko Journal: Soc Sci Med Date: 2015-09-25 Impact factor: 4.634
Authors: Peter S Hendricks; J Lee Westmaas; Van M Ta Park; Christopher B Thorne; Sabrina B Wood; Majel R Baker; R Marsh Lawler; Monica Webb Hooper; Kevin L Delucchi; Sharon M Hall Journal: Psychol Addict Behav Date: 2013-03-25
Authors: Whitney L Heppner; Claire Adams Spears; Virmarie Correa-Fernández; Yessenia Castro; Yisheng Li; Beibei Guo; Lorraine R Reitzel; Jennifer Irvin Vidrine; Carlos A Mazas; Ludmila Cofta-Woerpel; Paul M Cinciripini; Jasjit S Ahluwalia; David W Wetter Journal: Ann Behav Med Date: 2016-06